Cargando…

Salvaging CNS Clinical Trials Halted Due to COVID‐19

Detalles Bibliográficos
Autores principales:	Geerts, Hugo, van der Graaf, Piet H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283764/ https://www.ncbi.nlm.nih.gov/pubmed/32468710 http://dx.doi.org/10.1002/psp4.12535

Ejemplares similares

A modeling informed quantitative approach to salvage clinical trials interrupted due to COVID‐19
por: Geerts, Hugo, et al.
Publicado: (2020)

Novel strategies halt cardiovascular, diabetes, and cancer strips
por: Hu, Chun-Song, et al.
Publicado: (2017)

Application of quantitative systems pharmacology to guide the optimal dosing of COVID‐19 vaccines
por: Giorgi, Mario, et al.
Publicado: (2021)

Has the Time Come for Predictive Computer Modeling in CNS Drug Discovery and Development?
por: Geerts, H, et al.
Publicado: (2012)

Model‐informed target identification and validation through combining quantitative systems pharmacology with network‐based analysis
por: Chelliah, Vijayalakshmi, et al.
Publicado: (2022)

Halting the Allergic March
por: Van Bever, Hugo P, et al.
Publicado: (2008)

Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer’s Disease
por: Geerts, Hugo, et al.
Publicado: (2021)

Can The March of COVID-19 be Halted
por: Loomba, Poonam, et al.
Publicado: (2020)

Immunomodulatory approaches to CNS injury: extracellular matrix and exosomes from extracellular matrix conditioned macrophages
por: van der Merwe, Yolandi, et al.
Publicado: (2016)

Salvage treatment of relapsed/refractory LCH
por: Seo, Jong Jin
Publicado: (2016)

The role of social media during the COVID-19 pandemic: Salvaging its ‘power’ for positive social behaviour change in Africa
por: Madziva, Roda, et al.
Publicado: (2022)

Immunogenicity in Clinical Practice and Drug Development: When is it Significant?
por: Shakhnovich, Valentina, et al.
Publicado: (2019)

Hopeless Neuroma—The Neurotized Free Flap Tissue Augmentation as Salvage Therapy—A Concept and Clinical Demonstration
por: Aman, Martin, et al.
Publicado: (2023)

Skeletal muscle activity and CNS neuro-plasticity
por: Zhorne, Rachel, et al.
Publicado: (2016)

Holding Area LINQ Trial (HALT)
por: Lee, John J., et al.
Publicado: (2017)

Putting a Halt to HALT: Does Anticoagulation Matter?
por: DeAnda, Abe, et al.
Publicado: (2022)

Outside‐In Systems Pharmacology Combines Innovative Computational Methods With High‐Throughput Whole Vertebrate Studies
por: Schulthess, Pascal, et al.
Publicado: (2018)

Learn–confirm in model‐informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform
por: Franssen, Linnea C., et al.
Publicado: (2022)

Heterogeneity in COVID‐19 Convalescent Plasma Clinical Trials
por: Müller‐Olling, Mirco, et al.
Publicado: (2021)

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model
por: Geerts, Hugo, et al.
Publicado: (2023)

Antibody-based Validation of CNS Ion Channel Drug Targets
por: Rhodes, Kenneth J., et al.
Publicado: (2008)

Focusing on caveolin-1 in CNS autoimmune disease: multiple sclerosis
por: Wu, Hao, et al.
Publicado: (2016)

Genetically modifying transcription factors to promote CNS axon regeneration
por: Mehta, Saloni T., et al.
Publicado: (2017)

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
por: Thorlund, Kristian, et al.
Publicado: (2023)

Remote Monitoring in Clinical Trials During the COVID‐19 Pandemic
por: Izmailova, Elena S., et al.
Publicado: (2020)

Potassium channel blockers restore axonal conduction in CNS trauma and diseases
por: Page, Jessica C., et al.
Publicado: (2016)

Intracellular compartmentation of cAMP promotes neuroprotection and regeneration of CNS neurons
por: Cameron, Evan G., et al.
Publicado: (2017)

Monitor for COVID-19 vaccine resistance evolution during clinical trials
por: Kennedy, David A., et al.
Publicado: (2020)

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021)

Covid-19 and the politics of sustainable energy transitions
por: Kuzemko, Caroline, et al.
Publicado: (2020)

A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability
por: Sher, Anna, et al.
Publicado: (2022)

Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical Trial
por: Forrest, Jamie I., et al.
Publicado: (2022)

The choline pathway as a strategy to promote central nervous system (CNS) remyelination
por: Skripuletz, Thomas, et al.
Publicado: (2015)

Stem cells in the adult CNS revealed: examining their regulation by myelin basic protein
por: Xu, Wenjun, et al.
Publicado: (2016)

Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
por: Brown, Ronald B.
Publicado: (2021)

A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development
por: Spiros, Athan, et al.
Publicado: (2012)

Minimal brain PBPK model to support the preclinical and clinical development of antibody therapeutics for CNS diseases
por: Bloomingdale, Peter, et al.
Publicado: (2021)

Limb-salvage treatment of malignant pelvic bone tumor in China for past 20 years
por: Guo, Wei
Publicado: (2019)

Halting coronavirus polymerase
por: Kirchdoerfer, Robert N.
Publicado: (2020)

Halting 'research waste'
por: Shamsoddin, E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sdgkqk54vnuftv42og9nqg37fd